Refine Results
  1. "Lymphoma"
Formats
  1. Meeting Abstract (1027)
  2. Journal Article (917)
  3. Book Section (63)
  4. Review (34)
  5. Editorial (24)
  6. Research Letter (14)
  7. Conference Paper (12)
  8. Guidelines (11)
  9. Book Whole (4)
  10. Miscellaneous (4)
  11. Correspondence (1)
Groups
  1. Center for Hematologic Malignancies (2111)
  2. Department of Medicine (2111)
  3. Hematologic Malignancies, Division of (2111)
  4. Lymphoma (2111)
  5. Population Sciences Research Program (694)
  6. Survivorship Research (455)

More Groups

People
  1. Andrew Zelenetz (659)
  2. Steven Horwitz (504)
  3. David Straus (315)
  4. Anas Younes (295)
  5. Ariela Noy (289)
  6. Craig Moskowitz (267)

More People

Years
  1. 2022 (36)
  2. 2021 (122)
  3. 2020 (135)
  4. 2019 (223)
  5. 2018 (141)
  6. 2017 (162)

More Years

Publications
  1. Blood (602)
  2. Journal of Clinical Oncology (246)
  3. Hematological Oncology (88)
  4. British Journal of Haematology (68)
  5. Leukemia and Lymphoma (67)
  6. Annals of Oncology (55)

More Publications

Publishers
  1. American Society of Hematology (634)
  2. American Society of Clinical Oncology (261)
  3. Elsevier Inc. (149)
  4. Wiley Blackwell (145)
  5. John Wiley & Sons (83)
  6. Oxford University Press (83)

More Publishers

Results (2111)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in previously treated mantle cell lymphoma: Updated results from the phase 1/2 BRUIN study
    Meeting Abstract

    Wang, M.; Shah, N.; Alencar, A.; Gerson, J.; Patel, M.; Fakhri, B.; Jurczak, W.; Tan, X.; Lewis, K.; Fenske, T.; more...
    British Journal of Haematology (2022)

    Fulltext@MSK | Save
  • Characterization and outcomes in patients with mogamulizumab-associated skin reactions in the MAVORIC trial
    Meeting Abstract

    Musiek, A.; Whittaker, S.; Horwitz, S.; Bagot, M.; Huen, A.; Fisher, D.; Haun, P.; Vermeer, M.; Ito, T.; Dwyer, K.; more...
    British Journal of Haematology (2022)

    Fulltext@MSK | Save
  • Mosunetuzumab monotherapy is an effective and well-tolerated treatment option for patients with relapsed/refractory follicular lymphoma who have received ≥ 2 prior lines of therapy: Pivotal results from a phase I/II study
    Meeting Abstract

    Budde, E.; Sehn, L. H.; Matasar, M.; Schuster, S. J.; Assouline, S.; Giri, P.; Kuruvilla, J.; Canales, M.; Dietrich, S.; Fay, K.; more...
    British Journal of Haematology (2022)

    Fulltext@MSK | Save
  • Polatuzumab vedotin plus rituximab, cyclophosphamide, doxorubicin and prednisone (pola-R-CHP) versus rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) therapy in patients with previously untreated diffuse large B-cell lymphoma: Results from the phase III POLARIX study
    Meeting Abstract

    Tilly, H.; Morschhauser, F.; Sehn, L. H.; Friedberg, J. W.; Trněný, M.; Sharman, J. P.; Herbaux, C.; Burke, J. M.; Matasar, M.; Rai, S.; more...
    British Journal of Haematology (2022)

    Fulltext@MSK | Save
  • Immune profile of gastric cancers with expression of programmed death receptor ligand-1
    Meeting Abstract

    Abate, M. E.; Lin, Y. H.; Strong, V.; Vardhana, S.
    Annals of Surgical Oncology (2022)

    Fulltext@MSK | Save
  • Current treatment of peripheral T-cell lymphoma
    Review

    Stuver, R.; Epstein-Peterson, Z. D.; Johnson, W. T.; Khan, N.; Lewis, N.; Moskowitz, A. J.; Sauter, C. S.; Horwitz, S. M.
    Oncology (Norwalk) (2022)

    Fulltext@MSK | Save
  • Predictors of adequacy and adverse events during spleen biopsy in oncologic patients
    Meeting Abstract

    Kunin, H.; Wijetunga, N.; Erinjeri, J.; Noy, A.; Deipolyi, A.
    Journal of Vascular and Interventional Radiology (2022)

    Fulltext@MSK | Save
  • PD-1 improves accurate detection of Sezary cells by flow cytometry in peripheral blood in mycosis fungoides/Sezary syndrome
    Journal Article

    Lewis, N. E.; Gao, Q.; Petrova-Drus, K.; Pulitzer, M.; Sigler, A.; Baik, J.; Moskowitz, A. J.; Horwitz, S. M.; Dogan, A.; Roshal, M.
    Cytometry Part B—Clinical Cytometry (2022)

    Fulltext@MSK | Save
  • Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
    Journal Article

    Smith, M.; Dai, A.; Ghilardi, G.; Amelsberg, K. V.; Devlin, S. M.; Pajarillo, R.; Slingerland, J. B.; Beghi, S.; Herrera, P. S.; Giardina, P.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Characteristics and outcome of extranodal NK/T-cell lymphoma in North America: A retrospective multi-institutional experience
    Journal Article

    Bennani, N. N.; Tun, A. M.; Carson, K. R.; Geiger, J. L.; Maeda, L. S.; Savage, K. J.; Rose, J.; Pinter-Brown, L.; Lunning, M. A.; Abramson, J. S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save